Phenosulfonamide (etamsylate) is a hemostatic drug, which is often used for bleeding disorders, such as von purpura, hemorrhagic enteritis, gastrointestinal bleeding and menorrhagia. The following is a detailed introduction to the pharmacological effects, indications, dosage and adverse reactions of phenolsulfonamide
1.pharmachologic effect:
Phenylethylamide exerts hemostatic effects through a variety of mechanisms. It can increase the adhesion and aggregation of platelets and promote hemothrombosis.
In addition, phenosulfonamide can also increase the stability of the blood vessel wall and reduce the permeability of capillaries, thereby preventing bleeding in the blood vessels.
It also has the effect of constricting blood vessels, which can reduce the diameter of blood vessels, reduce blood flow, and help control bleeding.
2.Indications:
Phenol sulfonamide is mainly used for bleeding diseases caused by various reasons, such as vascular purpura, gastrointestinal bleeding, bleeding caused by pregnancy complications, and bleeding after surgery.
It can also be used for conditions such as menorrhagia and postpartum hemorrhage.
Phenylethylamide is an effective hemostatic drug that can be used for a variety of bleeding disorders. Attention should be paid to the dose, usage and adverse reactions when using and under the guidance of a doctor**.
CATO Standards specializes in providing standards for the phenosulfonyethylamine series.
Catalog numberChinese nameEnglish namecas
C4X-28541 Etamsylate Impurity 1
C4X-28542 Etamsylate Impurity 2
Guangzhou Jiatu Technology Co., Ltd. is the leading standard manufacturer, providing a full set of phenosulfonyethylamine impurities, strict quality control, through comprehensive testing, efficient communication, professional service, and perfect after-sales, all products can be spot.